top of page
DECISION INTELLIGENCE FOR MID-MARKET COMPANIES

Walk into your 2027 plan review with evidence, not assumptions

Independent, decision-grade answers on pricing, market entry, acquisitions, and new products — delivered in as little as 5 days, at a fixed price, in a format your CEO, board, or parent company will trust.

Excerpt from Sample Brief

Picture1.png
COMMON DECISIONS WE EVIDENCE
iStock-2217709477.jpg

The riskiest moment in your plan is the one nobody challenged.

​Most strategic decisions in mid-market companies are made on experience, internal data, and the confidence of the person presenting. That works until the market moves — and with tariffs, input costs, and pricing all in play for 2027, it is moving.

60% vs. 14%

Executives whose plans are formally challenged are over four times more likely to be confident those plans will succeed.

10.5% vs. 7.0%

Growth at companies that fully account for competition, compared with those that do not.

SOURCE: NCMM

THE SOLUTION

Clear, evidence-based answers delivered in days

5 days

FASTEST DECISION BRIEF

$10,000

FIXED PRICE, STARTING

Make confident winning decisions at the speed of business.

​​​​

ClearPath Decision Intelligence™ is specifically designed to help business leaders reduce the risk of important strategic decisions. Know the risks before you commit — and be able to show your board why.​​

BOUGHT RESEARCH BEFORE?

According to Greenbook Research Industry Trends (GRIT), business executives report only 25% satisfaction with the actionable recommendations produced by market research. ClearPath is built to answer the decision, not describe the market.

Decision risk assessment

Three minutes. Score the risk of the decision on your desk, then size what it is worth to reduce it.

STEP 1

Score your decision risk

STEP 2

Size the value of reducing it

STEP 3

High scores go to a scoping session

HOW IT WORKS

Start with the decision, not the data

Traditional market research gathers everything it can and hopes the answer is in there. ClearPath works backward from the decision you have to make and collects only the evidence that could change it. That focus is what lets us deliver decision-grade answers in days, at a fixed price.

No-1.png
No-2.png
No-3.png
No-4.png
No-5.png

​Strategic Decision Framing

We work collaboratively to pin down the strategic decision, the options on the table, what is at stake, and who has to be convinced.

WHY IT MATTERS

A tightly framed strategic decision sets the scope on day one, so nothing is wasted.

​Strategic Questions

We turn the decision into a short list of questions whose answers would actually change your choice.

WHY IT MATTERS

No boil-the-ocean study. If a question can't move the decision, we don't research it.

​Focused Data Collection

Targeted desk research, expert and customer interviews, and surveys, sized to your level of risk.

WHY IT MATTERS

Right-sized evidence means 5 to 25 days, not months.

​Synthesis and Clarity

Senior analysts weigh the evidence, surface what conflicts, and translate findings into clear answers.

WHY IT MATTERS

You get answers and implications, not a data dump.

​Decision Scorecard

A GO/NO-GO scorecard on market attractiveness, competition, headwinds and tailwinds, and risk to your existing business.

WHY IT MATTERS

A board-ready view your leadership can act on and defend.

Speed

Answers in 5 to 25 days, timed to your planning and approval calendar.

Value

Every hour goes to the questions that change the decision.

Fixed, published pricing with scope set up front. No open-ended retainers.

Cost

Trusted by manufacturers in a wide range of markets

3M Website.png
Tennant Website.png
Brady Website.png
Medtronic.png
CASE STUDIES

Decisions we've supported

BRADY CORPORATION

​

​How the product team won the argument with data

Strategic decision: Does Brady need to lower its prices to be more competitive and win more business?

TENNANT

​

The acquisition Tennant walked away from

Strategic decision: Should Tennant acquire an Ireland-based firm to help Tennant enter the European market?

BELLIN HEALTH

​

How the evidence moved a skeptical board

Strategic decision: Should Bellin Health create a branded walk-in clinic to compete with the fast-growing walk-in clinic market?

For the first time, I felt like I had a complete view of the market and our options.

Global HVAC Product Manufacturer​

​

ClearPath took a really complex decision and made it manageable and concrete.

Regional Healthcare System

The biggest value was the confidence to move ahead quickly instead of dragging this out six months.

Top 10 A&E Firm

PRICED FOR MID-MARKET BUDGETS

Four options to manage risk

The ClearPath studies are driven by strategic decision risk. The greater the risk, the greater the need for insight. With ClearPath, you choose the option that most effectively reduces your risk so you can effectively manage risk and ROI.

5 DAYS

​

ClearPath Screen

$10,000

FITS

A decision you need to pressure-test before taking it upstairs

  • Market Attractiveness​​

  • Competitive Intensity

  • Headwinds/Tailwinds

  • Risk to Existing Business

  • GO/NO-GO Ratings 

WHAT YOU RECEIVE

A decision brief, a one-page GO/NO-GO scorecard, and an executive readout.

10 DAYS

​

ClearPath Clarity

$15,000

FITS

An early-stage idea that needs outside validation

  • Market Attractiveness​​

  • Competitive Intensity

  • Headwinds/Tailwinds

  • Risk to Existing Business

  • GO/NO-GO Ratings 

  • 5 Market thought leader interviews

WHAT YOU RECEIVE

A decision brief, a one-page GO/NO-GO scorecard, and an executive readout.

20 DAYS

​

ClearPath Confidence

$20,000

FITS

An initial resource commitment

  • Market Attractiveness​​

  • Competitive Intensity

  • Headwinds/Tailwinds

  • Risk to Existing Business

  • GO/NO-GO Ratings

  • 5 Market thought leader interviews

  • Market sizing (TAM, SAM, and SOM)

  • 5 Voice of the Customer interviews 

WHAT YOU RECEIVE

A decision brief, a one-page GO/NO-GO scorecard, and an executive readout.

25 DAYS

​

ClearPath Conviction

$30,000

FITS

A major capital or acquisition commitment

  • Market Attractiveness​​

  • Competitive Intensity

  • Headwinds/Tailwinds

  • Risk to Existing Business

  • GO/NO-GO Ratings

  • 5 Market thought leader interviews

  • Market sizing (TAM, SAM, and SOM)

  • 5 Voice of the Customer interviews

  • Ecosystem intelligence: 5 competitor, 5 channel interviews

  • Curated market survey 

WHAT YOU RECEIVE

A decision brief, a one-page GO/NO-GO scorecard, and an executive readout.

Not sure which fits? Get a 30-minute decision scoping session with the ClearPath President.

Two ways to take the next step

I'M EXPLORING

​​

Get a Sample Brief

A 32-page redacted ClearPath Screen decision brief with GO/NO GO scorecard.

I HAVE A DECISION ON THE TABLE

​​

Book a Decision Scoping Session

30 minutes with the President. You receive a detailed decision intelligence proposal.

bottom of page